Pins matching place:Switzerland

Nestlé's first-half organic growth was 2.9%, almost all of it from pricing with real internal growth of just 0.2%, while reported sales fell 1.8% to CHF 44.2 billion on the strong franc. CEO Laurent Freixe kept 2025 guidance, including an underlying trading margin at or above 16.0%.

Nestlé's board dismissed Laurent Freixe with immediate effect after an investigation found an undisclosed romantic relationship with a direct subordinate, one year into his tenure. Nespresso chief Philipp Navratil, a Nestlé lifer who joined as an internal auditor in 2001, took over as CEO.

Former Inditex boss Pablo Isla took over as Nestlé's chairman on 1 October 2025, six months earlier than planned, after Paul Bulcke chose to step down in the wake of the CEO's dismissal. Dick Boer became Lead Independent Director and Vice Chairman.

In Philipp Navratil's first results as CEO, Nestlé's third-quarter organic growth rose to 4.3% with volumes (RIG) back up 1.5%, and it raised its cost-savings target to CHF 3.0 billion by 2027, including about 16,000 job cuts over two years. The shares closed 9.3% higher.

New CEO Philipp Navratil set out a global headcount reduction of about 16,000 - some 12,000 white-collar roles and 4,000 in manufacturing and supply chain - and raised Nestlé's Fuel for Growth savings target to CHF 3.0 billion by the end of 2027. The shares jumped more than 8%.

Swiss utility KWO finished building a new 113-metre arch dam directly in front of its cracked 1932 predecessor high in the Grimsel Pass.

After tracing the toxin cereulide to arachidonic acid (ARA) oil from a global supplier, Nestlé began recalling SMA, BEBA, NAN, Alfamino and Guigoz batches country by country from 5 January 2026, in more than 60 countries.

Nestlé grew 3.5% organically in 2025 on sales of CHF 89.5 billion, proposed a dividend of CHF 3.10 a share, up 5 centimes, and set out a focus on four businesses: Coffee, Petcare, Nutrition and Food & Snacks. It guided to around 3% to 4% organic growth in 2026.

At its 159th Annual General Meeting in Lausanne, Nestlé's shareholders re-elected Pablo Isla as Chair and elected former Swiss National Bank chairman Thomas Jordan and P&G executive Fama Francisco to the board. They also approved a CHF 3.10 dividend, the 30th consecutive increase.

Nestlé agreed to sell Blue Bottle Coffee, bought in 2017, to Centurium Capital, the biggest shareholder of China's Luckin Coffee, with the deal expected to close in the first half of 2026. The sale covers Blue Bottle's more than 100 cafes and most of its packaged-coffee business; Nestlé keeps the Blue Bottle Nespresso pods.

Nestlé grew 3.5% organically in the first quarter, led by coffee, even though its infant formula recall cut about 0.9 points off growth; reported sales fell 5.7% to CHF 21.3 billion on the strong franc. It kept its 2026 guidance.

Richemont's group sales rose to €22.4 billion, up 11% at constant exchange rates, with operating profit of €4.5 billion for the year ended 31 March 2026, led by its Jewellery Maisons Cartier and Van Cleef & Arpels.

Nestlé's first-half organic growth reached 3.6% and volumes (RIG) improved to 1.8% in the second quarter, but net profit fell 31.4% to CHF 3.5 billion on restructuring and a CHF 1.3 billion write-down of businesses it is selling. It kept its 3% to 4% growth guidance for 2026.

Nestlé will put S.Pellegrino, Perrier, Acqua Panna, Nestlé Pure Life and its other waters and premium beverages into Peranel, a 50:50 joint venture with Platinum Equity valued at EUR 4.9 billion. Nestlé expects about EUR 3.0 billion in cash at closing, due in the first half of 2027.

A WTO panel ruled on 28 July 2026 that Turkey's additional 40% tariff on Chinese-made electric vehicles and its discriminatory import permit rules breach trade rules, in a case China brought in October 2024.

Swiss-made monoblock power amplifier delivering 1,560 watts into 8 ohms.

On 21 August 2026 the International Electrotechnical Commission approved a China-led proposal for an international standard on solid-state traction batteries, starting a 24-36 month drafting process built on a 0.5% mass-loss threshold.

WMO expects the established El Niño to strengthen in the coming months and persist through February 2027, with increased risks of floods, drought and extreme heat. Its September–November outlook already anticipates rainfall and temperature patterns associated with strong El Niño.

Nestlé agreed to sell its mainstream vitamins business - Nature's Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan's Pride and Sisu, with its US private-label supplements and their plants - to Yellow Wood Partners for $1.0 billion. The business had $1.2 billion of sales in 2025; Nestlé keeps premium brands such as Solgar and Pure Encapsulations.

Swiss sportswear brand On entered football by signing Kylian Mbappé, sponsored by Nike since childhood, and named Thierry Henry its Director of Football; Mbappé will help develop On's first boots using its LightSpray robotic upper technology.

Toblerone Diamond Truffles with Biscoff pair a Biscoff spread filling with honey and almond nougat in milk chocolate, in a 180g box (£6.77) and a Costco-only 495g box.

At its Investor Day at On Labs in Zurich, On targeted high-teens constant-currency sales growth to at least CHF 5.6 billion in 2029 and an adjusted EBITDA margin of 22%+, and authorised its first share buyback, up to $1 billion through 2029.

WHO's Strategic Advisory Group of Experts on Immunization holds its autumn meeting on 5-8 October 2026 at WHO headquarters in hybrid format, by invitation only; the agenda is to be published nearer the time.

Nestlé reported CHF 22.756 billion Q3 sales and 4.0% organic growth. Nine-month reported sales were essentially flat at CHF 65.865 billion, with full-year guidance maintained.

Richemont's corporate calendar lists 13 November 2026 for its interim results covering the six months to 30 September 2026, the next scheduled test of the group's growth after a strong FY26 and Q1 FY27.

WHO's IHR Emergency Committee on the Bundibugyo Ebola epidemic is due to reconvene, roughly three months after its 18 August meeting, to say whether the emergency still stands. WHO counts 7,890 confirmed cases and 3,799 deaths in the DRC as of 23 September 2026.

WHO extended the polio Temporary Recommendations for a further three months from 21 August 2026, so the IHR Emergency Committee is expected to review whether polio remains a public health emergency around late November. Wild poliovirus type 1 stays confined to Afghanistan and Pakistan.

The board of Gavi, the Vaccine Alliance, holds its December 2026 meeting on 9-10 December, the governing body that oversees vaccine programmes for measles, malaria, cholera and other diseases in lower-income countries.

The Global Fund expects generic lenacapavir, the twice-yearly HIV prevention injection, to enter the market by the end of 2026, with 24 countries worldwide due to receive it by then. Nearly 100,000 people in nine high-burden African countries had received it by mid-August 2026.

Nestlé publishes its 2026 full-year results, the test of its 3% to 4% organic growth guidance and CHF 9 billion free-cash-flow target, a year after the results day on which it proposed its CHF 3.10 dividend for 2025.

WHO's Strategic Advisory Group of Experts on Immunization meets on 15-18 March 2027 at WHO headquarters in hybrid format, by invitation only.

The Intergovernmental Panel on Climate Change delivers the first special report devoted to climate change and cities, due in March 2027. It is one of three special and methodology reports in the AR7 cycle.

The World Health Assembly opens in Geneva on 23 May 2027 with the Pandemic Agreement's pathogen access and benefit-sharing (PABS) annex due for consideration after member states extended the negotiations in 2026.

Expected completion of the deal that moves S.Pellegrino, Perrier, Acqua Panna and Nestlé's other waters into Peranel, a 50:50 joint venture with Platinum Equity, paying Nestlé about EUR 3.0 billion (CHF 2.8 billion) in cash. Closing still needs employee consultations and regulatory approvals.

Expected completion of Yellow Wood Partners' $1.0 billion purchase of Nature's Bounty, Nuun, Osteo Bi-Flex, Ester-C, Gard, Puritan's Pride and Sisu from Nestlé, pending regulatory approvals. The carved-out business, with $1.2 billion of 2025 sales, will run as a standalone company.

Nestlé aims to finish cutting about 16,000 jobs and reach CHF 3.0 billion of Fuel for Growth cost savings by the end of 2027. By mid-2026 it reported CHF 1.7 billion of savings delivered.

The Global Polio Eradication Initiative's extended strategy sets certification of wild poliovirus type 1 eradication by the end of 2027, with transmission in Afghanistan and Pakistan meant to stop first. Both countries still report cases.

Roche's phase 3 trial of Enicepatide in obesity or overweight reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 2,000 participants. The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants without Type 2 diabetes mellitus (T2DM) who have obesity or overweight with at least one weight-related comorbidity.

An upgrade to increase the LHC's collision rate roughly tenfold, extending the search for rare processes into the 2040s. Estimated date.

Switzerland's second bore under the Gotthard Pass, approved by referendum in 2016 to let the original 1980 tunnel close for renovation without cutting off the A2, is on track to finish by 2030.